Novavax Appoints Charles Newton to Board of Directors

Charles Newton Charles Newton "Charles brings a wealth of expertise across corporate finance and capital markets to Novavax," said John C. Jacobs, President and Chief Executive Officer, Novavax. "The knowledge he brings to our already experienced board will be invaluable as we continue to execute our corporate growth strategy focused on forging strategic partnerships for our R&D assets and our Matrix-M® adjuvant." Mr. Newton currently serves as Chief Financial Officer of Lyell Immunopharma, with past leader ...